Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Amicus Therapeutics Net Income 2007-2020 | FOLD

For a detailed definition, formula and example for Net Income, check out our new background page here.
Amicus Therapeutics net income from 2007 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  
Amicus Therapeutics Annual Net Income
(Millions of US $)
2020 $-277
2019 $-356
2018 $-349
2017 $-284
2016 $-200
2015 $-132
2014 $-69
2013 $-60
2012 $-49
2011 $-44
2010 $-55
2009 $-7
2008 $-39
2007 $-42
2006 $-42
2005 $-20
Amicus Therapeutics Quarterly Net Income
(Millions of US $)
2020-12-31 $-71
2020-09-30 $-64
2020-06-30 $-52
2020-03-31 $-89
2019-12-31 $-90
2019-09-30 $-62
2019-06-30 $-85
2019-03-31 $-120
2018-12-31 $-78
2018-09-30 $-159
2018-06-30 $-62
2018-03-31 $-50
2017-12-31 $-69
2017-09-30 $-112
2017-06-30 $-48
2017-03-31 $-55
2016-12-31 $-59
2016-09-30 $-47
2016-06-30 $-51
2016-03-31 $-44
2015-12-31 $-43
2015-09-30 $-38
2015-06-30 $-27
2015-03-31 $-24
2014-12-31 $-21
2014-09-30 $-17
2014-06-30 $-15
2014-03-31 $-16
2013-12-31 $-12
2013-09-30 $-15
2013-06-30 $-15
2013-03-31 $-17
2012-12-31 $-10
2012-09-30 $-16
2012-06-30 $-9
2012-03-31 $-13
2011-12-31 $-9
2011-09-30 $-10
2011-06-30 $-13
2011-03-31 $-13
2010-12-31 $-15
2010-09-30 $-15
2010-06-30 $-11
2010-03-31 $-13
2009-12-31 $33
2009-09-30 $-13
2009-06-30 $-14
2009-03-31 $-12
2008-12-31 $-14
2008-09-30 $-8
2008-06-30 $-9
2008-03-31 $-8
2007-12-31 $-12
2007-09-30 $-10
2007-06-30 $-10
2007-03-31 $-10
2006-09-30 $-12
2006-06-30 $-28
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.730B $0.261B
AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $146.904B 15.37
Bristol Myers Squibb (BMY) United States $143.954B 10.01
CSL (CSLLY) Australia $95.156B 0.00
Gilead Sciences (GILD) United States $82.808B 9.28
Moderna (MRNA) United States $64.032B 0.00
Illumina (ILMN) United States $58.646B 89.32
Vertex Pharmaceuticals (VRTX) United States $57.225B 24.43
Regeneron Pharmaceuticals (REGN) United States $52.992B 17.32
Biogen (BIIB) United States $41.198B 8.24
Alexion Pharmaceuticals (ALXN) United States $34.803B 13.49
BioNTech SE (BNTX) Germany $33.987B 879.50
BeiGene (BGNE) Cayman Islands $28.227B 0.00
Seagen (SGEN) United States $27.131B 46.47
Genmab (GMAB) Denmark $22.942B 32.09
Exact Sciences (EXAS) United States $22.070B 0.00
Genmab (GNMSF) Denmark $21.772B 5.16
Horizon Therapeutics Public (HZNP) Ireland $20.953B 24.04
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Incyte (INCY) United States $18.291B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.932B 57.06
Alnylam Pharmaceuticals (ALNY) United States $16.310B 0.00
Bio-Techne Corp (TECH) United States $16.109B 92.26
Guardant Health (GH) United States $15.988B 0.00
Novavax (NVAX) United States $14.926B 0.00
Zai Lab (ZLAB) China $14.494B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.323B 114.16
ARGENX SE-ADR (ARGX) Netherlands $14.236B 0.00
QIAGEN (QGEN) Netherlands $12.013B 24.51
Repligen (RGEN) United States $11.698B 128.66
CRISPR Therapeutics AG (CRSP) Switzerland $9.342B 0.00
Mirati Therapeutics (MRTX) United States $8.307B 0.00
Fate Therapeutics (FATE) United States $7.915B 0.00
AbCellera Biologics (ABCL) $7.815B 0.00
Acceleron Pharma (XLRN) United States $7.510B 0.00
Exelixis (EXEL) United States $7.472B 68.43
Ultragenyx Pharmaceutical (RARE) United States $7.336B 0.00
Twist Bioscience (TWST) United States $6.911B 0.00
Denali Therapeutics (DNLI) United States $6.780B 215.54
Ascendis Pharma (ASND) Denmark $6.675B 0.00
Halozyme Therapeutics (HALO) United States $6.621B 51.33
Adaptive Biotechnologies (ADPT) United States $5.991B 0.00
NeoGenomics (NEO) United States $5.799B 707.71
Sarepta Therapeutics (SRPT) United States $5.768B 0.00
Vir Biotechnology (VIR) United States $5.764B 0.00
Blueprint Medicines (BPMC) United States $5.561B 18.31
Galapagos (GLPG) Belgium $5.201B 0.00
Intellia Therapeutics (NTLA) United States $5.064B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $4.982B 15.67
Biohaven Pharmaceutical Holding (BHVN) United States $4.705B 0.00
Beam Therapeutics (BEAM) United States $4.609B 0.00
Certara (CERT) United States $4.293B 0.00
I-Mab (IMAB) China $4.111B 0.00
Arena Pharmaceuticals (ARNA) United States $4.102B 0.00
Emergent Biosolutions (EBS) United States $3.990B 9.49
Atea Pharmaceuticals (AVIR) United States $3.807B 0.00
SpringWorks Therapeutics (SWTX) United States $3.605B 0.00
Apellis Pharmaceuticals (APLS) United States $3.598B 0.00
Insmed (INSM) United States $3.472B 0.00
Legend Biotech (LEGN) United States $3.432B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.393B 0.00
Reata Pharmaceuticals (RETA) United States $3.338B 0.00
Berkeley Lights (BLI) United States $3.252B 0.00
Seer (SEER) $3.226B 0.00
Alkermes (ALKS) Ireland $3.148B 0.00
Arvinas (ARVN) United States $3.079B 0.00
MorphoSys AG (MOR) Germany $3.050B 46.36
BAVARIAN NORDIC (BVNRY) Denmark $3.022B 42.81
Editas Medicine (EDIT) United States $2.761B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.722B 0.00
Vericel (VCEL) United States $2.673B 1159.60
Intra-Cellular Therapies (ITCI) United States $2.618B 0.00
Global Blood Therapeutics (GBT) United States $2.569B 0.00
Arcus Biosciences (RCUS) United States $2.480B 0.00
Ligand Pharmaceuticals (LGND) United States $2.473B 46.82
ALX Oncology Holdings (ALXO) United States $2.422B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.177B 0.00
Myriad Genetics (MYGN) United States $2.163B 0.00
Sorrento Therapeutics (SRNE) United States $2.125B 0.00
PHARMA MAR SA (PHMMF) Spain $2.074B 0.00
Revance Therapeutics (RVNC) United States $2.010B 0.00
NGM Biopharmaceuticals (NGM) United States $1.999B 0.00
Bluebird Bio (BLUE) United States $1.995B 0.00
Amarin (AMRN) Ireland $1.971B 0.00
Seres Therapeutics (MCRB) United States $1.958B 0.00
Inovio Pharmaceuticals (INO) United States $1.877B 0.00
Heska (HSKA) United States $1.871B 0.00
Morphic Holding (MORF) United States $1.798B 0.00
Cytokinetics (CYTK) United States $1.779B 0.00
Genetron Holdings (GTH) China $1.770B 0.00
Five Prime Therapeutics (FPRX) United States $1.770B 0.00
Kymera Therapeutics (KYMR) United States $1.728B 0.00
Castle Biosciences (CSTL) United States $1.703B 0.00
Bionano Genomics (BNGO) United States $1.703B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.699B 0.00
Sangamo Therapeutics (SGMO) United States $1.692B 0.00
PureTech Health (PRTC) United States $1.652B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.627B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.609B 0.00
Precigen (PGEN) United States $1.608B 0.00
BioAtla (BCAB) United States $1.601B 0.00
UniQure (QURE) Netherlands $1.596B 0.00
Codexis (CDXS) United States $1.581B 0.00
Travere Therapeutics (TVTX) United States $1.568B 0.00
REGENXBIO (RGNX) United States $1.525B 0.00
Keros Therapeutics (KROS) United States $1.477B 0.00
Alector (ALEC) United States $1.471B 0.00
Zealand Pharma (ZEAL) Denmark $1.424B 0.00
C4 Therapeutics (CCCC) United States $1.419B 0.00
Cara Therapeutics (CARA) United States $1.412B 353.88
Zymeworks (ZYME) Canada $1.393B 0.00
Nurix Therapeutics (NRIX) United States $1.374B 0.00
MiMedx (MDXG) United States $1.369B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.342B 0.00
Shattuck Labs (STTK) United States $1.323B 0.00
Repare Therapeutics (RPTX) Canada $1.259B 0.00
Dynavax Technologies (DVAX) United States $1.230B 0.00
Nkarta (NKTX) United States $1.203B 0.00
Mersana Therapeutics (MRSN) United States $1.192B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.188B 0.00
Avid Bioservices (CDMO) United States $1.185B 0.00
Protagonist Therapeutics (PTGX) United States $1.170B 0.00
Mesoblast (MESO) Australia $1.168B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Ocugen (OCGN) United States $1.157B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.138B 0.00
Curis (CRIS) United States $1.117B 0.00
Pliant Therapeutics (PLRX) United States $1.095B 0.00
Northwest Biotherapeutics (NWBO) United States $1.087B 0.00
MannKind (MNKD) United States $1.071B 0.00
Scholar Rock Holding (SRRK) United States $1.059B 0.00
G1 THERAPEUTICS (GTHX) United States $1.054B 0.00
Coherus BioSciences (CHRS) United States $1.041B 8.43
Arcturus Therapeutics Holdings (ARCT) United States $1.039B 0.00
Prothena (PRTA) Ireland $1.026B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.012B 0.00
Sutro Biopharma (STRO) United States $0.980B 0.00
Celldex Therapeutics (CLDX) United States $0.933B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.921B 39.02
Adverum Biotechnologies (ADVM) United States $0.919B 0.00
Prometheus Biosciences (RXDX) United States $0.915B 0.00
Bolt Biotherapeutics (BOLT) United States $0.884B 0.00
Merus (MRUS) Netherlands $0.873B 0.00
Pharming Group (PHAR) Netherlands $0.868B 0.00
Epizyme (EPZM) United States $0.838B 0.00
Affimed (AFMD) Germany $0.837B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.832B 0.00
Cellectis S.A (CLLS) France $0.826B 0.00
Pharming Group (PHGUF) Netherlands $0.814B 21.67
Inhibrx (INBX) United States $0.792B 0.00
Avidity Biosciences (RNA) United States $0.787B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.784B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.784B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.752B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.737B 0.00
VBI Vaccines (VBIV) United States $0.735B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.716B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.692B 0.00
DBV Technologies S.A (DBVT) France $0.687B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.678B 0.00
Kadmon Holdings (KDMN) United States $0.677B 0.00
Cel-Sci (CVM) United States $0.668B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Clovis Oncology (CLVS) United States $0.638B 0.00
MeiraGTx Holdings (MGTX) United States $0.633B 0.00
ALBIREO PHARMA (ALBO) United States $0.629B 0.00
Starpharma Holdings (SPHRY) Australia $0.609B 0.00
Compugen (CGEN) Israel $0.609B 0.00
AnaptysBio (ANAB) United States $0.604B 0.00
IDEAYA Biosciences (IDYA) United States $0.603B 0.00
Anika Therapeutics (ANIK) United States $0.586B 194.62
Adagene (ADAG) $0.571B 0.00
ChromaDex (CDXC) United States $0.569B 0.00
Agenus (AGEN) United States $0.544B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.539B 0.00
RAPT THERAPTICS (RAPT) United States $0.526B 0.00
Inventiva S.A (IVA) France $0.518B 0.00
Neoleukin Therapeutics (NLTX) United States $0.516B 0.00
Precision BioSciences (DTIL) United States $0.511B 0.00
AC Immune SA (ACIU) Switzerland $0.508B 0.00
XBiotech (XBIT) United States $0.506B 0.00
Amryt Pharma (AMYT) United Kingdom $0.502B 0.00
Forte Biosciences (FBRX) United States $0.497B 0.00
CytomX Therapeutics (CTMX) United States $0.496B 0.00
AMMO (POWW) United States $0.490B 0.00
Geron (GERN) United States $0.481B 0.00
Kala Pharmaceuticals (KALA) United States $0.468B 0.00
Verastem (VSTM) United States $0.462B 0.00
Selecta Biosciences (SELB) United States $0.442B 0.00
Angion Biomedica (ANGN) United States $0.438B 0.00
Gritstone Oncology (GRTS) United States $0.433B 0.00
ANI Pharmaceuticals (ANIP) United States $0.430B 11.99
XOMA (XOMA) United States $0.426B 94.63
Fortress Biotech (FBIO) United States $0.421B 0.00
AquaBounty Technologies (AQB) United States $0.420B 0.00
Seelos Therapeutics (SEEL) United States $0.413B 0.00
Adicet Bio (ACET) United States $0.412B 0.00
Puma Biotechnology (PBYI) United States $0.411B 0.00
Syros Pharmaceuticals (SYRS) United States $0.401B 0.00
Cue Biopharma (CUE) United States $0.394B 0.00
Opthea (OPT) Australia $0.394B 0.00
Spero Therapeutics (SPRO) United States $0.394B 0.00
SESEN BIO, INC (SESN) United States $0.393B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.393B 0.00
Fulcrum Therapeutics (FULC) United States $0.389B 0.00
Athenex (ATNX) United States $0.385B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.382B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.381B 0.00
UROGEN PHARMA (URGN) United States $0.379B 0.00
Athersys (ATHX) United States $0.370B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.365B 0.00
Trevena (TRVN) United States $0.363B 0.00
SQZ Biotechnologies (SQZ) United States $0.354B 0.00
BioDelivery Sciences (BDSI) United States $0.350B 13.88
Innate Pharma S.A (IPHA) France $0.348B 0.00
Bellus Health (BLU) Canada $0.344B 0.00
Theratechnologies (THTX) Canada $0.338B 0.00
Cogent Biosciences (COGT) United States $0.338B 0.00
Frequency Therapeutics (FREQ) United States $0.335B 0.00
Oncobiologics (OTLK) United States $0.330B 0.00
Cardiff Oncology (CRDF) United States $0.330B 0.00
HOOKIPA Pharma (HOOK) United States $0.329B 0.00
Kaleido Biosciences (KLDO) $0.321B 0.00
WAVE Life Sciences (WVE) Singapore $0.311B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.310B 0.00
Arbutus Biopharma (ABUS) United States $0.308B 0.00
Codiak BioSciences (CDAK) United States $0.293B 0.00
CorMedix Inc (CRMD) United States $0.291B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.290B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Kamada (KMDA) Israel $0.282B 16.23
IBio (IBIO) United States $0.279B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.276B 0.00
Protalix BioTherapeutics (PLX) Israel $0.271B 0.00
NextCure (NXTC) United States $0.261B 0.00
OVID THERAPEUTC (OVID) United States $0.251B 0.00
VTv Therapeutics (VTVT) United States $0.236B 0.00
Cerecor (CERC) United States $0.232B 0.00
Checkpoint Therapeutics (CKPT) United States $0.223B 0.00
Prima BioMed (IMMP) Australia $0.219B 0.00
ADMA Biologics Inc (ADMA) United States $0.210B 0.00
Eton Pharmaceuticals (ETON) United States $0.209B 0.00
Kindred Biosciences (KIN) United States $0.206B 0.00
LogicBio Therapeutics (LOGC) United States $0.199B 0.00
TELA Bio (TELA) United States $0.197B 0.00
OSMOTICA PHARM (OSMT) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.193B 0.00
Aptinyx (APTX) United States $0.186B 0.00
GENFIT S.A (GNFT) France $0.185B 0.00
DiaMedica Therapeutics (DMAC) United States $0.185B 0.00
Voyager Therapeutics (VYGR) United States $0.178B 4.97
VolitionRX (VNRX) United States $0.174B 0.00
Applied Genetic Technologies (AGTC) United States $0.173B 0.00
Nicox SA (NICXF) France $0.172B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.171B 0.00
Chiasma (CHMA) United States $0.169B 0.00
Enzo Biochem (ENZ) United States $0.167B 0.00
Strongbridge Biopharma (SBBP) United States $0.167B 0.00
Antibe Therapeutics (ATBPF) Canada $0.162B 0.00
Exicure (XCUR) United States $0.162B 0.00
INmune Bio (INMB) United States $0.161B 0.00
ObsEva SA (OBSV) Switzerland $0.161B 0.00
Clearside Biomedical (CLSD) United States $0.158B 0.00
Biofrontera AG (BFRA) Germany $0.157B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.155B 0.00
Erytech Pharma SA (ERYP) France $0.152B 0.00
X4 Pharmaceuticals (XFOR) United States $0.152B 0.00
Catalyst Biosciences (CBIO) United States $0.151B 0.00
Abeona Therapeutics (ABEO) United States $0.149B 0.00
Dyadic (DYAI) United States $0.140B 0.00
Eyenovia (EYEN) United States $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.138B 0.00
Palatin Technologies (PTN) United States $0.133B 0.00
Evofem Biosciences (EVFM) United States $0.130B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.129B 0.00
Liminal BioSciences (LMNL) Canada $0.127B 0.00
Orgenesis (ORGS) United States $0.127B 260.00
Synlogic (SYBX) United States $0.125B 0.00
TRACON Pharmaceuticals (TCON) United States $0.121B 0.00
Galena Biopharma (SLS) United States $0.119B 0.00
Aytu BioPharma (AYTU) United States $0.119B 0.00
Liquidia Technologies (LQDA) United States $0.119B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.117B 0.00
Aptevo Therapeutics (APVO) United States $0.115B 0.00
Beyond Air (XAIR) United States $0.113B 0.00
Evogene (EVGN) Israel $0.110B 0.00
Zosano Pharma (ZSAN) United States $0.108B 0.00
Ecology Coatings (ABVC) United States $0.107B 0.00
Novogen (KZIA) Australia $0.107B 0.00
ARAVIVE, INC (ARAV) United States $0.107B 0.00
Cidara Therapeutics (CDTX) United States $0.105B 0.00
Armata Pharmaceuticals (ARMP) United States $0.103B 0.00
Leap Therapeutics (LPTX) United States $0.101B 0.00
Lumos Pharma (LUMO) United States $0.099B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
PHASEBIO PHARMA (PHAS) United States $0.094B 0.00
Cleveland BioLabs (CBLI) United States $0.093B 0.00
Celsion (CLSN) United States $0.089B 0.00
Cocrystal Pharma (COCP) United States $0.086B 0.00
Cyclerion Therapeutics (CYCN) United States $0.085B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.085B 0.00
Vascular Biogenics (VBLT) Israel $0.083B 0.00
CytRx (CYTR) United States $0.082B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.081B 0.00
AIkido Pharma (AIKI) United States $0.080B 0.00
Adocia (ADOCY) France $0.077B 0.00
Edesa Biotech (EDSA) Canada $0.070B 0.00
Vaccinex (VCNX) United States $0.069B 0.00
Purple Biotech (PPBT) Israel $0.068B 0.00
BioCardia (BCDA) United States $0.067B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.067B 0.00
Timber Pharmaceuticals (TMBR) United States $0.065B 0.00
Emmaus Life Sciences (EMMA) United States $0.064B 0.00
ARIDIS PHARMACT (ARDS) United States $0.064B 0.00
AnPac Bio-Medical Science (ANPC) China $0.063B 0.00
Advaxis (ADXS) United States $0.063B 0.00
Organovo Holdings (ONVO) United States $0.062B 0.00
Alimera Sciences (ALIM) United States $0.059B 0.00
ATyr Pharma (LIFE) United States $0.059B 0.00
Genetic Technologies (GENE) Australia $0.059B 0.00
ZIVO Bioscience (ZIVO) United States $0.058B 0.00
Windtree Therapeutics (WINT) United States $0.057B 0.00
AEterna Zentaris (AEZS) United States $0.057B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.057B 0.00
Soligenix (SNGX) United States $0.056B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Pulmatrix (PULM) United States $0.053B 0.00
Enveric Biosciences (ENVB) United States $0.052B 0.00
Enzon Pharmaceuticals (ENZN) United States $0.051B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.048B 0.00
Happiness Biotech Group (HAPP) China $0.048B 0.00
Yumanity Therapeutics (YMTX) United States $0.047B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Cyclo Therapeutics (CYTH) United States $0.043B 0.00
Clene (CLNN) United States $0.043B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.040B 0.00
Invo BioScience (INVO) United States $0.040B 0.00
Vyant Bio (VYNT) United States $0.040B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.56
Sonnet BioTherapeutics Holdings (SONN) United States $0.037B 0.00
IMMURON (IMRN) Australia $0.032B 0.00
Vallon Pharmaceuticals (VLON) United States $0.032B 0.00
ThermoGenesis Holdings (THMO) United States $0.031B 0.00
GeoVax Labs (GOVX) United States $0.030B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.026B 0.00
Seneca Biopharma (SNCA) United States $0.025B 0.00
Benitec Biopharma (BNTC) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.009B 0.00
China Biologic Products (CBPO) China $0.000B 29.30
Entera Bio (ENTX) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00